Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus

doi:10.3748/wjg.v19.i48.9282

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 48

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7081)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

460

HTML

4435

Figures (1-3)

203

Tables (1-5)

252

Sum=5350

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1068

Download

663

Sum=1731

Dec 28, 2013 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (42)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Dec 28, 2013; 19(48): 9282-9293
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9282

Full Size Figure Download Figure

Figure 2 Percentage of patients who received neoadjuvant chemotherapy (n = 136) having lymph node downstaging grouped by Tumour Regression Grade. LN: Lymph node.

Citation: Noble F, Nolan L, Bateman AC, Byrne JP, Kelly JJ, Bailey IS, Sharland DM, Rees CN, Iveson TJ, Underwood TJ, Bateman AR. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus. World J Gastroenterol 2013; 19(48): 9282-9293
URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9282.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9282